Market Cap 6.43M
Revenue (ttm) 19.63M
Net Income (ttm) -60.48M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -308.10%
Debt to Equity Ratio 0.00
Volume 5,067,500
Avg Vol 11,315,736
Day's Range N/A - N/A
Shares Out 41.79M
Stochastic %K 0%
Beta 2.06
Analysts Sell
Price Target $1.00

Company Profile

Carisma Therapeutics, Inc., a biotechnology company, focuses on developing transformative therapies to treat liver fibrosis and cancer in the United States. Its product candidates include CT-2401, which is in preclinical trial for the treatment of liver fibrosis. The company also develops CT-1119, a mesothelin-targeted CAR-Monocyte that is in phase I clinical trial to treat patients with advanced mesothelin-positive solid tumors, including pancreatic cancer, ovarian cancer, lung cancer, mesothel...

Industry: Biotechnology
Sector: Healthcare
Phone: 267 491 6422
Address:
3675 Market Street, Suite 401, Philadelphia, United States
atason
atason May. 29 at 8:21 PM
$CARM what happend to my $4.X sesen shares
2 · Reply
AnUnwiseInvestor
AnUnwiseInvestor May. 28 at 5:57 PM
$SLS Seeking Alpha is trash. BioStat News? That’s when you should know you are fucked. $SESN $CARM 🤨
1 · Reply
BarrenWuffet57
BarrenWuffet57 May. 27 at 1:36 PM
$CLSK VERY BULLISH UPDATE FROM CANTOR TODAY! SEES FAIR VALUE OF GW PORTFOLIO AT 54/share! «A few months ago, the only site that we thought CLSK could lease was Sandersville (250 MW). However, that has now changed with Wyoming (110 MW), Jackson (60 MW), College Park (50 MW), Washington (86 MW), Austin county (285 MW), and Brazoria County (300 MW) now in play. Should all of these sites get leased, we estimate the pipeline value to be worth ~$54/share. With shares trading at ~$17, it feels like ~33% of its near-term leasable portfolio is being priced in.»
0 · Reply
DaSqueeza
DaSqueeza May. 25 at 8:38 PM
$CARM wow! This is soon a 100 stock
0 · Reply
BillionaireMotion
BillionaireMotion May. 24 at 10:46 AM
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor May. 23 at 12:05 AM
0 · Reply
MilsLearning
MilsLearning May. 22 at 7:53 PM
$CARM 🩳🔥🖕
0 · Reply
Barrett50
Barrett50 May. 19 at 8:16 PM
$CARM do you temember the experation date of the CVR
1 · Reply
ArtemisArbitrage
ArtemisArbitrage May. 15 at 10:07 AM
$CARM this trade is boring but a good one
1 · Reply
jcooptechit
jcooptechit May. 14 at 7:01 PM
$CELZ MAY BE NEARING A MAJOR BIOTECH INFLECTION POINT Creative Medical Technology is heading into a key May 2026 catalyst with top-line Phase 2 data expected for CELZ-201-DDT in chronic low-back pain linked to DDD. 🔸 Phase 2 clinical readout pending 🔸 Chronic pain / DDD = massive market 🔸 Multiple active Phase 2 programs 🔸 DSMB previously supported trial continuation 🔸 No Phase 3 results yet, so this is still early — but high-impact Strong data could quickly change the CELZ narrative and bring serious attention back to its regenerative medicine platform. This next update could be the spark. Communicated - Disclaimer: https://fh.bio/jcoop Sector Peers: $ABEO $ALLO $AUTL $CARM
0 · Reply
Latest News on CARM
No data available.
atason
atason May. 29 at 8:21 PM
$CARM what happend to my $4.X sesen shares
2 · Reply
AnUnwiseInvestor
AnUnwiseInvestor May. 28 at 5:57 PM
$SLS Seeking Alpha is trash. BioStat News? That’s when you should know you are fucked. $SESN $CARM 🤨
1 · Reply
BarrenWuffet57
BarrenWuffet57 May. 27 at 1:36 PM
$CLSK VERY BULLISH UPDATE FROM CANTOR TODAY! SEES FAIR VALUE OF GW PORTFOLIO AT 54/share! «A few months ago, the only site that we thought CLSK could lease was Sandersville (250 MW). However, that has now changed with Wyoming (110 MW), Jackson (60 MW), College Park (50 MW), Washington (86 MW), Austin county (285 MW), and Brazoria County (300 MW) now in play. Should all of these sites get leased, we estimate the pipeline value to be worth ~$54/share. With shares trading at ~$17, it feels like ~33% of its near-term leasable portfolio is being priced in.»
0 · Reply
DaSqueeza
DaSqueeza May. 25 at 8:38 PM
$CARM wow! This is soon a 100 stock
0 · Reply
BillionaireMotion
BillionaireMotion May. 24 at 10:46 AM
0 · Reply
AnUnwiseInvestor
AnUnwiseInvestor May. 23 at 12:05 AM
0 · Reply
MilsLearning
MilsLearning May. 22 at 7:53 PM
$CARM 🩳🔥🖕
0 · Reply
Barrett50
Barrett50 May. 19 at 8:16 PM
$CARM do you temember the experation date of the CVR
1 · Reply
ArtemisArbitrage
ArtemisArbitrage May. 15 at 10:07 AM
$CARM this trade is boring but a good one
1 · Reply
jcooptechit
jcooptechit May. 14 at 7:01 PM
$CELZ MAY BE NEARING A MAJOR BIOTECH INFLECTION POINT Creative Medical Technology is heading into a key May 2026 catalyst with top-line Phase 2 data expected for CELZ-201-DDT in chronic low-back pain linked to DDD. 🔸 Phase 2 clinical readout pending 🔸 Chronic pain / DDD = massive market 🔸 Multiple active Phase 2 programs 🔸 DSMB previously supported trial continuation 🔸 No Phase 3 results yet, so this is still early — but high-impact Strong data could quickly change the CELZ narrative and bring serious attention back to its regenerative medicine platform. This next update could be the spark. Communicated - Disclaimer: https://fh.bio/jcoop Sector Peers: $ABEO $ALLO $AUTL $CARM
0 · Reply
TradesBB
TradesBB May. 14 at 12:12 PM
$CARM the management at sesn and ebio and the fda should be looked into for the bs pulled on this one. Vicineum showed promise and investors were mislead on whole FDA approval actions
1 · Reply
ALdudei
ALdudei May. 13 at 9:16 PM
$CARM market cap 12k? Lmao
0 · Reply
HercMelo
HercMelo May. 12 at 10:08 PM
$CARM crushed it today. Hahaha 🤣🤣🤣🤣
0 · Reply
3DxLabs
3DxLabs May. 12 at 1:41 PM
$CARM maybe our CVRs won’t be worthless? 🤣
0 · Reply
HercMelo
HercMelo May. 11 at 9:14 PM
$CARM MC 20k hahahahahahahah. Trash
0 · Reply
MarkMonkey
MarkMonkey May. 6 at 5:46 PM
$CARM any chance of a bounce back here given modernas interest?
0 · Reply
TradesBB
TradesBB Apr. 28 at 2:41 PM
$CARM I could have probably made my money back if Etrade let me buy this at .0001-2 a few days ago. What bs
1 · Reply
G_eo_mo
G_eo_mo Apr. 27 at 7:51 PM
$CARM To the moon..;)
0 · Reply
HercMelo
HercMelo Apr. 27 at 7:08 PM
$CARM crushing it hahaahahaha
0 · Reply
TradesBB
TradesBB Apr. 27 at 5:39 PM
$CARM what bs. Now that you can't buy this can go up
0 · Reply
GeoMo
GeoMo Apr. 27 at 2:59 PM
$CARM Holding up nicely…;)
0 · Reply
PhantomZ
PhantomZ Apr. 26 at 7:39 PM
$CARM Make it all back! $TLTFF SESN screwed you over! They had a laughable CR result of 17% at 12 months after 36 treatments vs 33% CR for One Single Treatment with $TLTFF Ruvidar. https://stockhouse.com/news/press-releases/2026/04/13/theralase-r-reports-complete-response-with-x-ray-activated-rutherrin-r-in-muscle
1 · Reply